Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBMs Object To Real-Time Prior Authorization In E-Prescribing

Executive Summary

Several pharmacy benefit managers are opposing making real-time prior authorization part of electronic prescribing systems

You may also be interested in...



Electronic Prior Authorization Costs Should Be Measured In Pilot – Cmte.

The cost implications of automated prior authorization should be measured under the HHS pilot program on electronic prescribing, the National Committee on Vital & Health Statistics/Standards & Security Subcommittee said

Electronic Prior Authorization Costs Should Be Measured In Pilot – Cmte.

The cost implications of automated prior authorization should be measured under the HHS pilot program on electronic prescribing, the National Committee on Vital & Health Statistics/Standards & Security Subcommittee said

E-Prescribing Standards Should Limit Marketing, Rx Bias – Sen. Grassley

Electronic prescribing standards should prohibit commercial messages that could influence physician decisions, Senate Finance Committee Chair Chuck Grassley (R-Iowa) said

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044480

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel